Table 2 Baseline characteristics between symptomatic and asymptomatic patients
From: Meta-analysis of reported presacral myelolipomas, including a report of a new case
|  | Symptomatic (n = 34) | Asymptomatic (n = 20) | p-Value |
|---|---|---|---|
Age (years) | 65.2 (IQR 61.5–74.0) | 68.5 (IQR 58.3–79.8) | n.s. |
Sex, n (% male) | 10 (29.4%) | 4 (20.0%) | n.s. |
Average size (cm) | 7.46 cm (IQR 4.08–11.00 cm) | 6.74 cm (IQR 4.88–8.04 cm) | n.s. |
Treatment, n (% resection) | 20 (58.9%) | 10 (50.0%) | n.s. |